HUMAN HEALTH: 2025 Interim Report

HKEXMar 25 12:01 · Announcements

The Consumers Council advocates that private Medical Institutions should enhance price transparency to avoid 'shock bills'.

The Consumer Council published a research report indicating that the fee transparency of Private Medical Institutions is still insufficient. It recommends that the government clearly require private institutions to provide patients with a clear and written estimate of service costs before treatment. The Council's Secretary-General, Huang Fengxian, stated on a radio program that the research found some patients want to utilize their full Medical insurance compensation limits or are persuaded by medical institutions to use more services, worrying that this will increase long-term social medical costs. Both Insurance companies and Consumers will have to bear higher medical expenses and premiums, creating a vicious cycle. Private medical institutions should enhance price transparency, allowing patients to have a certain budget and ensuring higher certainty in charges, avoiding 'shock billing.'

AASTOCKSMar 7 11:18

Human Health's Fiscal H1 Profit Declines 16%

MT NewswiresFeb 27 15:25

《Performance》HUMAN HEALTH (01419.HK) mid-term net profit is 16.82 million yuan, a 16% decline, no dividend distributed.

HUMAN HEALTH (01419.HK) announced its interim results for the six months ending December 2024, with revenue of 0.316 billion yuan, an increase of 7% year-on-year. It recorded a net profit of 16.82 million yuan, a decline of 16%, with earnings per share of 4.4 cents. No interim dividend will be distributed.

AASTOCKSFeb 27 00:07

HUMAN HEALTH (01419) released its interim results, with profit attributable to Shareholders at 16.822 million HKD, a decrease of 16.03% year-on-year.

HUMAN HEALTH (01419) released the interim results for the six months ending December 31, 2024, with a revenue of 3.1...

Zhitong FinanceFeb 26 20:31

HUMAN HEALTH (01419.HK) reported a mid-term revenue of approximately 0.316 billion Hong Kong dollars, representing an increase of about 7.0% year-on-year.

Gelonghui, February 26 - HUMAN HEALTH (01419.HK) announced that for the six months ending December 31, 2024, the group's interim income is approximately 315.8 million HKD, an increase of about 20.6 million HKD or 7.0% compared to the interim of the 2024 fiscal year. The profit attributable to the shareholders of the company is approximately 16.8 million HKD, a decrease of about 3.2 million HKD or 16.0% compared to the interim of the 2024 fiscal year. Excluding the fair value changes of financial assets accounted for at fair value through profit or loss and the fair value changes of investment properties, the profit attributable to the shareholders of the group is approximately 22 million HKD, compared to the 2024 fiscal year.

Gelonghui FinanceFeb 26 20:27